Bioethics Carmel Shachar FDA Health Law Policy Human Subjects Research Immunization Petrie-Flom Center Population-Level Bioethics Public Health Resource Allocation Vaccines What You Should Know About the COVID-19 Vaccine Read more: What You Should Know About the COVID-19 Vaccine
Bioethics Biotechnology FDA Featured Health Law Policy Human Subjects Research Pharmaceuticals Public Health Sravya Chary Vaccines Challenges in COVID-19 Vaccine Rollout: Lessons from the UK Read more: Challenges in COVID-19 Vaccine Rollout: Lessons from the UK
Bioethics FDA Featured Health Law Policy Human Subjects Research Immunization Population-Level Bioethics Public Health Resource Allocation Ross D. Silverman Vaccines From “A Spoonful of Sugar” to Operation Warp Speed: COVID-19 Vaccines and Their Metaphors Read more: From “A Spoonful of Sugar” to Operation Warp Speed: COVID-19 Vaccines and Their Metaphors
FDA Featured Health Law Policy Immunization Public Health Vaccines Authorize Emergency Vaccines for COVID-19, but Do It Well Read more: Authorize Emergency Vaccines for COVID-19, but Do It Well
FDA Featured Health Law Policy Immunization Public Health Vaccines Why the Government Shouldn’t Pay People to Get Vaccinated Against COVID-19 Read more: Why the Government Shouldn’t Pay People to Get Vaccinated Against COVID-19
Dorit Reiss FDA Featured Health Law Policy Immunization Public Health Vaccines Under an EUA, Can Businesses Require Employees and Customers to Get Vaccinated? Read more: Under an EUA, Can Businesses Require Employees and Customers to Get Vaccinated?
Dorit Reiss FDA Featured Health Law Policy Immunization Public Health Resource Allocation Vaccines What Does the Good News on the Vaccine Front Mean? Read more: What Does the Good News on the Vaccine Front Mean?
Biotechnology Generic Drugs Intellectual Property Pharmaceuticals Roche and City of Hope Claim Pfizer Biosimilar Version of Trastuzumab Will Infringe “At Least” 40 Patents Read more: Roche and City of Hope Claim Pfizer Biosimilar Version of Trastuzumab Will Infringe “At Least” 40 Patents
Judicial Opinions Kate Greenwood Liability Pharmaceuticals Kaiser v. Pfizer and the Question of Who Pays When Fraudulent Pharmaceutical Promotion Has Its Intended Effect Read more: Kaiser v. Pfizer and the Question of Who Pays When Fraudulent Pharmaceutical Promotion Has Its Intended Effect